Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Interaction of Serum Antibodies from Breast Cancer Patients with Synthetic Peptides.

Podlesnykh SV, Kolosova EA, Shcherbakov DN, Shaidurov AA, Anisimov DS, Ryazanov MA, Johnston SA, Shoikhet YN, Petrova VD, Lazarev AF, Chapoval AI.

Bull Exp Biol Med. 2016 Oct;161(6):816-820. Epub 2016 Oct 26.

PMID:
27783295
2.

Semaphorins 4A and 4D in chronic inflammatory diseases.

Chapoval SP, Vadasz Z, Chapoval AI, Toubi E.

Inflamm Res. 2017 Feb;66(2):111-117. doi: 10.1007/s00011-016-0983-5. Epub 2016 Aug 23. Review.

PMID:
27554682
3.

Immunosignature: Serum Antibody Profiling for Cancer Diagnostics.

Chapoval AI, Legutki JB, Stafford P, Trebukhov AV, Johnston SA, Shoikhet YN, Lazarev AF.

Asian Pac J Cancer Prev. 2015;16(12):4833-7. Review.

4.

The anti-lymphoma activities of anti-CD137 monoclonal antibodies are enhanced in FcγRIII(-/-) mice.

Sallin MA, Zhang X, So EC, Burch E, Cai L, Lin W, Chapoval AI, Strome SE.

Cancer Immunol Immunother. 2014 Sep;63(9):947-58. doi: 10.1007/s00262-014-1567-2. Epub 2014 Jun 14.

PMID:
24927849
5.

BTNL8, a butyrophilin-like molecule that costimulates the primary immune response.

Chapoval AI, Smithson G, Brunick L, Mesri M, Boldog FL, Andrew D, Khramtsov NV, Feshchenko EA, Starling GC, Mezes PS.

Mol Immunol. 2013 Dec;56(4):819-28. doi: 10.1016/j.molimm.2013.08.003.

PMID:
24036152
6.

Interleukin-7 inhibits tumor-induced CD27-CD28- suppressor T cells: implications for cancer immunotherapy.

Zhang Y, Pfannenstiel LW, Bolesta E, Montes CL, Zhang X, Chapoval AI, Gartenhaus RB, Strome SE, Gastman BR.

Clin Cancer Res. 2011 Aug 1;17(15):4975-86. doi: 10.1158/1078-0432.CCR-10-3328. Epub 2011 Jun 28.

7.

Activation of cytokine-producing and antitumor activities of natural killer cells and macrophages by engagement of Toll-like and NOD-like receptors.

Qiu F, Maniar A, Diaz MQ, Chapoval AI, Medvedev AE.

Innate Immun. 2011 Aug;17(4):375-87. doi: 10.1177/1753425910372000. Epub 2010 Aug 3.

PMID:
20682587
8.

Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.

Maniar A, Zhang X, Lin W, Gastman BR, Pauza CD, Strome SE, Chapoval AI.

Blood. 2010 Sep 9;116(10):1726-33. doi: 10.1182/blood-2009-07-234211. Epub 2010 Jun 2.

9.

Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells.

Urban EM, Chapoval AI, Pauza CD.

Clin Dev Immunol. 2010;2010:732893. doi: 10.1155/2010/732893. Epub 2010 Apr 13. Review.

10.

CD137 promotes proliferation and survival of human B cells.

Zhang X, Voskens CJ, Sallin M, Maniar A, Montes CL, Zhang Y, Lin W, Li G, Burch E, Tan M, Hertzano R, Chapoval AI, Tamada K, Gastman BR, Schulze DH, Strome SE.

J Immunol. 2010 Jan 15;184(2):787-95. doi: 10.4049/jimmunol.0901619. Epub 2009 Dec 11.

11.

Th17/Tc17 infiltration and associated cytokine gene expression in elicitation phase of allergic contact dermatitis.

Zhao Y, Balato A, Fishelevich R, Chapoval A, Mann DL, Gaspari AA.

Br J Dermatol. 2009 Dec;161(6):1301-6. doi: 10.1111/j.1365-2133.2009.09400.x. Epub 2009 Jul 7.

12.

A central role for transcription factor C/EBP-beta in regulating CD1d gene expression in human keratinocytes.

Sikder H, Zhao Y, Balato A, Chapoval A, Fishelevich R, Gade P, Singh IS, Kalvakolanu DV, Johnson PF, Gaspari AA.

J Immunol. 2009 Aug 1;183(3):1657-66. doi: 10.4049/jimmunol.0900057. Epub 2009 Jul 10. Erratum in: J Immunol. 2009 Sep 15;183(6):4135.

13.

FcgammaRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck.

Taylor RJ, Chan SL, Wood A, Voskens CJ, Wolf JS, Lin W, Chapoval A, Schulze DH, Tian G, Strome SE.

Cancer Immunol Immunother. 2009 Jul;58(7):997-1006. doi: 10.1007/s00262-008-0613-3. Epub 2008 Nov 1. Erratum in: Cancer Immunol Immunother. 2009 Sep;58(9):1527-8.

PMID:
18979096
14.

Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.

Alexander AA, Maniar A, Cummings JS, Hebbeler AM, Schulze DH, Gastman BR, Pauza CD, Strome SE, Chapoval AI.

Clin Cancer Res. 2008 Jul 1;14(13):4232-40. doi: 10.1158/1078-0432.CCR-07-4912.

15.

Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion.

Montes CL, Chapoval AI, Nelson J, Orhue V, Zhang X, Schulze DH, Strome SE, Gastman BR.

Cancer Res. 2008 Feb 1;68(3):870-9. doi: 10.1158/0008-5472.CAN-07-2282.

16.

Inhibition of in vitro and in vivo T cell responses by recombinant human Tim-1 extracellular domain proteins.

Mesri M, Smithson G, Ghatpande A, Chapoval A, Shenoy S, Boldog F, Hackett C, Pena CE, Burgess C, Bendele A, Shimkets RA, Starling GC.

Int Immunol. 2006 Mar;18(3):473-84. Epub 2006 Feb 15.

PMID:
16481347
17.

B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells.

Luo L, Chapoval AI, Flies DB, Zhu G, Hirano F, Wang S, Lau JS, Dong H, Tamada K, Flies AS, Liu Y, Chen L.

J Immunol. 2004 Nov 1;173(9):5445-50.

18.

Ligation of CD137 receptor prevents and reverses established anergy of CD8+ cytolytic T lymphocytes in vivo.

Wilcox RA, Tamada K, Flies DB, Zhu G, Chapoval AI, Blazar BR, Kast WM, Chen L.

Blood. 2004 Jan 1;103(1):177-84. Epub 2003 Sep 11.

19.

B7-H4, a molecule of the B7 family, negatively regulates T cell immunity.

Sica GL, Choi IH, Zhu G, Tamada K, Wang SD, Tamura H, Chapoval AI, Flies DB, Bajorath J, Chen L.

Immunity. 2003 Jun;18(6):849-61.

20.

Immunoglobulin fusion proteins as a tool for evaluation of T-cell costimulatory molecules.

Chapoval AI, Zhu G, Chen L.

Mol Biotechnol. 2002 Jul;21(3):259-64.

PMID:
12102550
21.

Cutting edge: Expression of functional CD137 receptor by dendritic cells.

Wilcox RA, Chapoval AI, Gorski KS, Otsuji M, Shin T, Flies DB, Tamada K, Mittler RS, Tsuchiya H, Pardoll DM, Chen L.

J Immunol. 2002 May 1;168(9):4262-7.

22.

Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.

Strome SE, Voss S, Wilcox R, Wakefield TL, Tamada K, Flies D, Chapoval A, Lu J, Kasperbauer JL, Padley D, Vile R, Gastineau D, Wettstein P, Chen L.

Cancer Res. 2002 Mar 15;62(6):1884-9.

23.

Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors.

Wilcox RA, Flies DB, Zhu G, Johnson AJ, Tamada K, Chapoval AI, Strome SE, Pease LR, Chen L.

J Clin Invest. 2002 Mar;109(5):651-9.

24.

Reassessment of CD62L as a marker of pre-effector T cells in the tumor draining lymph nodes of head and neck cancer patients.

Strome SE, Martin E, Flies D, Khurana D, Salomao D, Tamada K, Chapoval AI, Kasperbauer JL, Olsen KD, Chen L.

Otolaryngol Head Neck Surg. 2002 Feb;126(2):180-7.

PMID:
11870350
25.

Allergic inflammatory response to short ragweed allergenic extract in HLA-DQ transgenic mice lacking CD4 gene.

Chapoval SP, Iijima K, Marietta EV, Smart MK, Chapoval AI, Andrews AG, David CS.

J Immunol. 2002 Jan 15;168(2):890-9.

26.

Hidden variables: unstable Abeta chain genes encoding antigen recognition structures in tumor survivors.

Liu Y, McMinimy DL, Savinov AY, Johnson KA, Kremlev SG, Chapoval AI, Egorov IK.

Mol Immunol. 2000 Dec;37(18):1091-110.

PMID:
11451415
27.

The A beta 6w302 gene and molecular mechanisms of resistance to the spread of radiation-induced lymphoma in a mouse mutant, survivor-27.

Liu Y, Savinov AY, McMinimy DL, Kremlev SG, Chapoval AI, Egorov IK.

Radiats Biol Radioecol. 2000 Sep-Oct;40(5):500-5.

PMID:
11252225
28.

B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.

Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K, Chen L.

Nat Immunol. 2001 Mar;2(3):269-74.

PMID:
11224528
29.

LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response.

Tamada K, Shimozaki K, Chapoval AI, Zhai Y, Su J, Chen SF, Hsieh SL, Nagata S, Ni J, Chen L.

J Immunol. 2000 Apr 15;164(8):4105-10.

31.

Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS.

Wang S, Zhu G, Chapoval AI, Dong H, Tamada K, Ni J, Chen L.

Blood. 2000 Oct 15;96(8):2808-13.

32.
33.
34.

Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway.

Tamada K, Shimozaki K, Chapoval AI, Zhu G, Sica G, Flies D, Boone T, Hsu H, Fu YX, Nagata S, Ni J, Chen L.

Nat Med. 2000 Mar;6(3):283-9.

PMID:
10700230
35.

Immunoglobulin fusion proteins as a tool for evaluation of T-cell costimulatory molecules.

Chapoval AI, Zhu G, Chen L.

Methods Mol Med. 2000;45:247-55. doi: 10.1385/1-59259-079-9:247.

PMID:
21341062
36.

Induction of antitumor immunity after cure of pulmonary metastases, using staphylococcal enterotoxin B and bispecific antibody.

Rice DC, Chapoval AI, Porter L, Nelson H.

Cancer Immunol Immunother. 1999 Aug;48(5):230-8.

PMID:
10478639
37.
40.

T cell activation and retargeting using staphylococcal enterotoxin B and bispecific antibody: an effective in vivo antitumor strategy.

Porter LE, Nelson H, Ethem Gecim I, Rice DC, Thibault C, Chapoval AI.

Cancer Immunol Immunother. 1997 Nov-Dec;45(3-4):180-3.

PMID:
9435868
41.

Differential sensitivity of mouse mononuclear phagocytes to CSF-1 and LPS: the potential in vivo relevance of enhanced IL-6 gene expression.

Kamdar SJ, Chapoval AI, Phelps J, Fuller JA, Evans R.

Cell Immunol. 1996 Dec 15;174(2):165-72.

PMID:
8954616
42.
43.

Bifunctional antibody retargeting in vivo-activated T lymphocytes: simplifying clinical application.

Chapoval AI, Nelson H, Thibault C, Penna C, Dean P.

J Hematother. 1995 Dec;4(6):571-7.

PMID:
8846018
44.

Anti-CD3 x anti-tumor F(ab')2 bifunctional antibody activates and retargets tumor-infiltrating lymphocytes.

Chapoval AI, Nelson H, Thibault C.

J Immunol. 1995 Aug 1;155(3):1296-303.

PMID:
7636196

Supplemental Content

Loading ...
Support Center